Azelastine nasal spray 137 mcg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Azelastine nasal spray 137 mcg, covering 2011-05-10 to 2011-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis [Phase 4]